TUMOR NECROSIS FACTOR-INDUCED C-MYC EXPRESSION IN THE ABSENCE OF MITOGENESIS IS ASSOCIATED WITH INHIBITION OF ADIPOCYTE DIFFERENTIATION

被引:33
|
作者
NINOMIYATSUJI, J [1 ]
TORTI, FM [1 ]
RINGOLD, GM [1 ]
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,STANFORD,CA 94305
关键词
D O I
10.1073/pnas.90.20.9611
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumor necrosis factor (TNF) inhibits and reverses differentiation of mouse adipogenic TA1 cells. We have found that TNF induces c-myc in a sustained manner in both preadipocytes and adipocytes; in contrast, serum induces c-myc transiently and only in preadipocytes. This TNF-mediated c-myc induction is not coupled with cell proliferation but is correlated with TNF-mediated inhibition of adipocyte differentiation. We prepared an inducible c-myc transformant of TA1 cells by transfection of the mouse c-myc gene under the control of the metallothionein-I promoter. These cells are unable to differentiate to adipocytes in the presence of Zn2+/Cd2+, and in differentiated TA1 cells, Zn2+/Cd2+ causes reduction of adipocyte-specific gene expression as does TNF. Lastly, exposure of TA1 cells to antisense c-myc oligonucleotide partially blocked the TNF-mediated reduction of adipocyte-specific gene expression. Thus, TNF-mediated c-myc expression is distinct in character from that involved in mitogenic responses but appears to play an important role in inhibition and reversal of adipocyte differentiation.
引用
收藏
页码:9611 / 9615
页数:5
相关论文
共 50 条
  • [31] Differentiation Inducing Factor-1 Represses c-Myc and VEGF Expression in Myeloma Cells
    Kumari, Rajni
    Khan, Rehan
    Sharma, Alpana
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (04): : 189 - 198
  • [32] INHIBITION BY INTERLEUKIN-4 OF LEUKEMIA INHIBITORY FACTOR-INDUCED, INTERLEUKIN 6-INDUCED, AND DEXAMETHASONE-INDUCED DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS - ROLE OF C-MYC AND JUNB PROTOONCOGENES
    KASUKABE, T
    OKABEKADO, J
    HOZUMI, M
    HONMA, Y
    CANCER RESEARCH, 1994, 54 (02) : 592 - 597
  • [33] Expression of E- and P-selectin in tumor necrosis factor-induced dermatitis in dogs
    Tremblay, C
    Paradis, M
    Doré, M
    VETERINARY PATHOLOGY, 2001, 38 (03) : 261 - 268
  • [34] THE EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA ON EXPRESSION OF PROTOONCOGENES C-MYC AND C-RAS AND THE ACCUMULATION OF CAMP IN ROS 17/2.8 CELLS
    ZHANG, JM
    DU, GG
    YANG, FY
    GU, WX
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S258 - S258
  • [35] Inhibition of tumor necrosis factor-induced apoptosis in transgenic mice liver expressing creatine kinase.
    Hatano, E
    Tanaka, A
    Kanazawa, A
    Satoh, S
    Shinohara, H
    Tsunekawa, S
    Iwata, S
    Takahashi, R
    Chance, B
    Yamaoka, Y
    GASTROENTEROLOGY, 1997, 112 (04) : A1279 - A1279
  • [36] Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-Myc pathways to inhibit platelet-derived growth factor-induced mitogenesis
    Zhao, MM
    Janas, JA
    Niki, M
    Pandolfi, PP
    Van Aelst, L
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) : 2479 - 2489
  • [37] Inhibition of Tumor Necrosis Factor-induced necrotic cell death by the zinc finger protein A20
    Heyninck, K
    Denecker, G
    De Valck, D
    Fiers, W
    Beyaert, R
    ANTICANCER RESEARCH, 1999, 19 (4B) : 2863 - 2868
  • [38] REGULATION OF C-MYC AND N-MYC EXPRESSION DURING INDUCED-DIFFERENTIATION OF MURINE NEUROBLASTOMA-CELLS
    LARCHER, JC
    VAYSSIERE, JL
    LOSSOUARN, L
    GROS, F
    CROIZAT, B
    ONCOGENE, 1991, 6 (04) : 633 - 638
  • [39] TUMOR NECROSIS FACTOR-INDUCED ENDOTHELIAL TISSUE FACTOR IS ASSOCIATED WITH SUBENDOTHELIAL MATRIX VESICLES BUT IS NOT EXPRESSED ON THE APICAL SURFACE
    RYAN, J
    BRETT, J
    TIJBURG, P
    BACH, RR
    KISIEL, W
    STERN, D
    BLOOD, 1992, 80 (04) : 966 - 974
  • [40] EXPRESSION OF MAD, MXI1, MAX AND C-MYC DURING INDUCED-DIFFERENTIATION OF HEMATOPOIETIC-CELLS - OPPOSITE REGULATION OF MAD AND C-MYC
    LARSSON, LG
    PETTERSSON, M
    OBERG, F
    NILSSON, K
    LUSCHER, B
    ONCOGENE, 1994, 9 (04) : 1247 - 1252